Women’s health has been considered a niche market for way too long. With women accounting for half of the world’s population and 80% of consumer purchasing decisions in the healthcare industry*, pharma has no time to waste in embracing enormous opportunities for investment, value creation and, ultimately, improving women’s lives.

As the first waves of major change in perception of women’s health are on the rise, we are taking a deeper dive at the present and the future of FemTech, and pharma’s role in bridging the gender health gap locally and globally.

Join us for this vibrant women-led discussion to explore the unique role digital can play in improving outcomes for conditions affecting women differently or disproportionately. Learn from our experts how to:

•  create a focused digital health strategy by understanding women’s health better, looking at regional differences, and separating market hype from facts

•  close gender-based healthcare delivery and access gaps thanks to value-lead, sustainable partnerships with FemTech start-ups and NGOs
•  improve outcomes by embracing gender-diversified design among your digital products and solutions

Sign up today to participate in the discussion and ask questions of our expert panel or listen on-demand.

This webinar is run in conjunction with the Reuters Events: Pharma 2024 event in Barcelona (16-18 April 2024). Check out our Digital Health stage details for more information.

* “General facts on women and job-based health”, Employee Benefits Security Administration fact sheet, US Department of Labour